Clinical Trial Update: Sequential High-dose Dexamethasone and Response Adopted PAD or VAD Induction Chemotherapy Followed by High-dose Chemotherapy With Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial tested sequential high-dose dexamethasone followed by PAD or VAD induction chemotherapy and then high-dose chemotherapy with autologous stem cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Yonsei University | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED